-transparent.png){kind=logo}
A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF versus single-tablet regimen efavirenz/emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results. 2014
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
*Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC †Community Research Initiative of New England, Boston, MA ‡Southwest Care Center, Santa Fe, NM §Anthony Mills MD Inc, Los Angeles, CA ‖Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA ¶Orlando Immunology Center, Orlando, FL #Division of Infectious Diseases and Geographic Medicine, Stanford University, Palo Alto, CA **Gilead Sciences, Foster City, CA.
Related Publications
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
March 2014,
Journal of acquired immune deficiency syndromes (1999),
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
January 2015,
Antiviral therapy,
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
April 2013,
Journal of acquired immune deficiency syndromes (1999),
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
January 2014,
HIV clinical trials,
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
December 2012,
The Annals of pharmacotherapy,
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
March 2011,
AIDS (London, England),
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
May 2016,
Journal of acquired immune deficiency syndromes (1999),
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
May 2017,
HIV clinical trials,
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
June 2017,
Journal of acquired immune deficiency syndromes (1999),
David A Wohl, and
Calvin Cohen, and
Joel E Gallant, and
Anthony Mills, and
Paul E Sax, and
Edwin Dejesus, and
Andrew Zolopa, and
Hui C Liu, and
Andrew Plummer, and
Kirsten L White, and
Andrew K Cheng, and
Martin S Rhee, and
Javier Szwarcberg, and
July 2017,
HIV clinical trials,
